Search Results - "Ciccarese, M"

Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers by Ruggeri, M., Pagan, E., Bagnardi, V., Bianco, N., Gallerani, E., Buser, K., Giordano, M., Gianni, L., Rabaglio, M., Freschi, A., Cretella, E., Clerico, M., Farolfi, A., Simoncini, E., Ciccarese, M., Rauch, D., Ramello, M., Glaus, A., Berardi, R., Pellanda, A. Franzetti, Ribi, K., Gelber, S., Partridge, A.H., Goldhirsch, A., Pagani, O.

“…Most research addressing needs and concerns of young patients with breast cancer (≤40 years) is retrospective. The HOHO European protocol is a prospective…”
Get full text

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients by Trevisan, B., Pepe, F. F., Vallini, I., Montagna, E., Amoroso, D., Berardi, R., Butera, A., Cagossi, K., Cavanna, L., Ciccarese, M., Cinieri, S., Cretella, E., De Conciliis, E., Febbraro, A., Ferraù, F., Ferzi, A., Baldelli, A., Fontana, A., Gambaro, A. R., Garrone, O., Gebbia, V., Generali, D., Gianni, L., Giovanardi, F., Grassadonia, A., Leonardi, V., Sarti, S., Musolino, A., Nicolini, M., Putzu, C., Riccardi, F., Santini, D., Sarobba, M. G., Schintu, M. G., Scognamiglio, G., Spadaro, P., Taverniti, C., Toniolo, D., Tralongo, P., Turletti, A., Valenza, R., Valerio, M. R., Vici, P., Clivio, L., Torri, V., Cazzaniga, M. E.

“…Nowadays, treatment of metastatic breast cancer (MBC) has been enriched with novel therapeutical strategies. Metronomic chemotherapy (mCHT) is a continuous and…”
Get full text

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study by Cazzaniga, M. E., Cortesi, L., Ferzi, A., Scaltriti, L., Cicchiello, F., Ciccarese, M., Della Torre, S., Villa, F., Giordano, M., Verusio, C., Nicolini, M., Gambaro, A. R., Zanlorenzi, L., Biraghi, E., Legramandi, L., Rulli, E.

“…Purpose The VICTOR-1 study demonstrated that the all-oral metronomic combination of vinorelbine and capecitabine is highly active and well tolerated in hormone…”
Get full text

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study by Cazzaniga, M.E., Pinotti, G., Montagna, E., Amoroso, D., Berardi, R., Butera, A., Cagossi, K., Cavanna, L., Ciccarese, M., Cinieri, S., Cretella, E., De Conciliis, E., Febbraro, A., Ferraù, F., Ferzi, A., Fiorentini, G., Fontana, A., Gambaro, A.R., Garrone, O., Gebbia, V., Generali, D., Gianni, L., Giovanardi, F., Grassadonia, A., Leonardi, V., Marchetti, P., Melegari, E., Musolino, A., Nicolini, M., Putzu, C., Riccardi, F., Santini, D., Saracchini, S., Sarobba, M.G., Schintu, M.G., Scognamiglio, G., Spadaro, P., Taverniti, C., Toniolo, D., Tralongo, P., Turletti, A., Valenza, R., Valerio, M.R., Vici, P., Clivio, L., Torri, V., Cicchiello, F., Riva, F., Vallini, I., Mazza, M., Bonfadini, C., Bordin, E., Canicattì, M., Cappuccio, F., Collovà, E., De Angelis, C., Desorte, R., Donati, S., Drudi, G., Galanti, D., Mocerino, C., Orlando, L., Pellegrino, B., Pizzuti, L., Ridolfi, C., Rocca, A., Sarti, D., Spagnoletti, I., Tinari, N., Vandone, A., Vizzini, L.

“…Metronomic chemotherapy (mCHT) refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen, with no…”
Get full text

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study by Cazzaniga, M. E., Vallini, I., Montagna, E., Amoroso, D., Berardi, R., Butera, A., Cagossi, K., Cavanna, L., Ciccarese, M., Cinieri, S., Cretella, E., De Conciliis, E., Febbraro, A., Ferraù, F., Ferzi, A., Baldelli, A., Fontana, A., Gambaro, A. R., Garrone, O., Gebbia, V., Generali, D., Gianni, L., Giovanardi, F., Grassadonia, A., Leonardi, V., Marchetti, P., Sarti, S., Musolino, A., Nicolini, M., Putzu, C., Riccardi, F., Santini, D., Saracchini, S., Sarobba, M. G., Schintu, M. G., Scognamiglio, G., Spadaro, P., Taverniti, C., Toniolo, D., Tralongo, P., Turletti, A., Valenza, R., Valerio, M. R., Vici, P., Di Mauro, P., Cogliati, V., Capici, S., Clivio, L., Torri, V.

“…Purpose Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor…”
Get full text

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study by Cazzaniga, M.E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G.V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M.C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V., Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M.R., Vici, P., Zambelli, A., Clivio, L., Torri, V., Alù, M., Ancona, C., Andreis, D., Bajardi, E., Benedetto, C., Berardi, R., Bordin, E., Butti, C., Capri, G., Cicchiello, F., Cocciolone, V., Dester, M., D'Onofrio, L., Febbraro, A., Ferrarini, I., Fotia, V., Gervasi, E., Guaitoli, G., Licata, L., Liscia, N., Mentuccia, L., Miraglio, E., Nicolini, M., Paternò, E., Pedani, F., Pellegrini, D., Petrucelli, L., De Laurentiis, M., Pizzuti, L., Pogliani, C., Riva, F.

“…The BOLERO-2 trial reported efficacy and safety of Everolimus (EVE) and Exemestane (EXE) combination in HR+ advanced breast cancer (ABC) patients. The BALLET…”
Get full text

Brain metastases and ado-trastuzumab emtansine (TDM-1) treatment in HER2 positive metastatic patients: an Italian multicenter analysis by Fabi, A, Alesini, D, Valle, E, Carbognin, L, Arpino, G, Santini, D, Montemurro, F, Ciccarese, M, Cannita, K, Paris, I, Moscetti, L, De Laurentiis, M, Zambelli, A, La Verde, N, Nisticò, C, Ferretti, G, Gasparro, S, Giannarelli, D, Cognetti, F

Get full text

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study by LORUSSO, V, GIOTTA, F, BORDONARO, R, MAIELLO, E, DEL PRETE, S, GEBBIA, V, FILIPELLI, G, PISCONTI, S, CINIERI, S, ROMITO, S, RICCARDI, F, FORCIGNANÒ, R, CICCARESE, M, PETRUCELLI, L, SARACINO, V, LUPO, L.I, GAMBINO, A, LEO, S, COLUCCI, G

“…We conducted a phase III multicenter randomized trial to compare the efficacy of the combination of liposome encapsulated doxorubicin (Myocet©) plus either…”
Get full text

1849 Italian observational study of Eribulin Mesylate in patients with advanced breast cancer: ESEMPiO study by Barni, S, Fontanella, C, Del Mastro, L, Livraghi, L, Morritti, M, Pizzuti, L, Michelotti, A, Lutrino, E.S, Ciccarese, M, Musolino, A, Quercia, S, Garrone, O, Pellegrino, A, Pistelli, M, Martella, F, Iezzi, L, Mentuccia, L, Latorre, A, D'Onofrio, L, Porcu, L

Get full text

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? by Giordano, M., Verusio, C., Gambaro, A. R., Zanlorenzi, L., Biraghi, E., Casini, E., Legramandi, L., Rulli, E., Villa, F., Torre, S. Della, Ciccarese, M., Cicchiello, F., Scaltriti, L., Ferzi, A., Cortesi, Laura, Cazzaniga, M. E., Nicolini, Mario

“…Triple-negative breast cancer (TNBC) shows a very bad prognosis, even in early stages of disease. Metronomic chemotherapy refers to the minimum biologically…”
Get full text

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients by Tonolo, G., Melis, M. G., Formato, M., Angius, M. F., Carboni, A., Brizzi, P., Ciccarese, M., Cherchi, G. M., Maioli, M.

“…Background Experimental evidence indicates that statins might have direct vascular effects independently from low‐density lipoprotein (LDL) cholesterol…”
Get full text

Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer by Di Cosimo, S., Alimonti, A., Ferretti, G., Sperduti, I., Carlini, P., Papaldo, P., Fabi, A., Gelibter, A., Ciccarese, M., Giannarelli, D., Mandalà, M., Milella, M., Ruggeri, E. M., Cognetti, F.

“…Background: The aim of this study was to characterize the factors associated with chemotherapy-induced amenorrhea (CIA) and to examine whether the phase of the…”
Get full text

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials by FERRETTI, G, BRIA, E, CECERE, F. L, GELIBTER, A, NUZZO, C, COGNETTI, F, TERZOLI, E, CARLINI, P, GIANNARELLI, D, FELICI, A, PAPALDO, P, FABI, A, DI COSIMO, S, RUGGERI, E. M, MILELLA, M, CICCARESE, M

“…The purpose of this study was to estimate in all randomised trials the relative risk of overall response rate (ORR), clinical benefit (CB), time to progression…”
Get full text

De Novo Everolimus-Based Therapy in Renal Transplant Recipients: Effect on Proteinuria and Renal Prognosis by Loriga, G, Ciccarese, M, Pala, P.G, Satta, R.P, Fanelli, V, Manca, M.L, Serra, G, Dessole, P, Cossu, M

“…Abstract Background In large-scale clinical trials, the proliferation signal inhibitor (PSI) everolimus (EVL) combined with cyclosporine (CsA) and steroids,…”
Get full text

Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment by TONOLO, G, CICCARESE, M, BRIZZI, P, PUDDU, L, SECCHI, G, CALVIA, P, ATZENI, M. M, MELIS, M. G, MAIOLI, M

“…Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment. G Tonolo , M Ciccarese ,…”
Get full text

A New Locus for Autosomal Recessive Hypercholesterolemia Maps to Human Chromosome 15q25-q26 by Ciccarese, Milco, Pacifico, Adolfo, Tonolo, Giancarlo, Pintus, Paolo, Nikoshkov, Andrej, Zuliani, Giovanni, Fellin, Renato, Luthman, Holger, Maioli, Mario

“…High serum cholesterol is an established risk factor for cardiovascular disease and is the prime target for therapeutic intervention in large groups of…”
Get full text

Does low-molecular-weight heparin influence cancer-related mortality? by Ferretti, G, Bria, E, Giannarelli, D, Carlini, P, Felici, A, Mandalà, M, Papaldo, P, Fabi, A, Ciccarese, M, Cognetti, F

Get full text

Chemotherapy-induced amenorrhea in early breast cancer by Ferretti, G., Carlini, P., Bria, E., Felici, A., Giannarelli, D., Ciccarese, M., Papaldo, P., Fabi, A., Cognetti, F.

Get full text

Molecular stool testing for the early detection of colorectal cancer: swan song for p53? by Ferretti, G., Felici, A., Ciccarese, M., Papaldo, P., Carlini, P., Fabi, A., Gelibter, A., Cognetti, F.

Get full text

Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden? by Ferretti, G., Bria, E., Felici, A., Carlini, P., Giannarelli, D., Ciccarese, M., Papaldo, P., Fabi, A., Gelibter, A., Cognetti, F.

Get full text